- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 417/02 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings
Patent holdings for IPC class C07D 417/02
Total number of patents in this class: 145
10-year publication summary
|
9
|
9
|
7
|
6
|
5
|
2
|
12
|
2
|
10
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4814 |
4 |
| Boehringer Ingelheim International GmbH | 4552 |
4 |
| Betta Pharmaceuticals Co., Ltd. | 175 |
4 |
| Calithera Biosciences, Inc. | 38 |
3 |
| ChemoCentryx, Inc. | 370 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2622 |
3 |
| MethylGene Inc. | 37 |
3 |
| Montelino Therapeutics, Inc. | 6 |
3 |
| F. Hoffmann-La Roche AG | 7832 |
2 |
| LG Chem, Ltd. | 17805 |
2 |
| Genentech, Inc. | 4052 |
2 |
| Bayer HealthCare LLC | 1308 |
2 |
| Sumitomo Chemical Company, Limited | 9046 |
2 |
| C4 Therapeutics, Inc. | 93 |
2 |
| Dong Wha Pharmaceutical Co. Ltd. | 11 |
2 |
| Emory University | 1693 |
2 |
| Gilead Sciences, Inc. | 2177 |
2 |
| Inventiva | 87 |
2 |
| Medshine Discovery Inc. | 593 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 855 |
2 |
| Other owners | 94 |